In fact, Myhre et al. found elevated levels of GDF-15 in most of in-hospital COVID-19 patients, and were associated with higher SARS-CoV2 viremia, hypoxaemia, and worse outcome [12]. The gene discussed is GDF15; the disease is COVID-19.